Terms: = Kidney tumors AND uPA AND Treatment
16 results:
1. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
[TBL] [Abstract] [Full Text] [Related]
2. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.
Liu X; Liu X; Sunchen S; Liu M; Shen C; Wu J; Zhao W; Yu B; Liu J
Drug Deliv; 2017 Nov; 24(1):1811-1817. PubMed ID: 29172777
[TBL] [Abstract] [Full Text] [Related]
3. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography.
Gurka MK; Pender D; Chuong P; Fouts BL; Sobelov A; McNally MW; Mezera M; Woo SY; McNally LR
J Control Release; 2016 Jun; 231():60-7. PubMed ID: 26763377
[TBL] [Abstract] [Full Text] [Related]
4. Reduced gene expression of bikunin as a prognostic marker for renal cell carcinoma.
Bayraktar E; Igci M; Erturhan S; Igci YZ; Karakok M; Gogebakan B; Ulasli M; Cakmak EA; Arslan A
Exp Oncol; 2014 Jun; 36(2):107-11. PubMed ID: 24980765
[TBL] [Abstract] [Full Text] [Related]
5. Urokinase gene 3'-UTR T/C polymorphism is associated with malignancy and ESRD in idiopathic membranous nephropathy.
Chen CH; Chen SY; Shu KH; Wen MC; Cheng CH; Wu MJ; Yu TM; Chuang YW; Tsai FJ
Biomed Res Int; 2014; 2014():425095. PubMed ID: 24822208
[TBL] [Abstract] [Full Text] [Related]
6. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway.
Wang XF; Zhou QM; Du J; Zhang H; Lu YY; Su SB
Anticancer Agents Med Chem; 2013 Jul; 13(6):923-31. PubMed ID: 23387975
[TBL] [Abstract] [Full Text] [Related]
7. BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer.
Jiang J; Thyagarajan-Sahu A; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Oncol Rep; 2012 Oct; 28(4):1139-45. PubMed ID: 22842551
[TBL] [Abstract] [Full Text] [Related]
8. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract] [Full Text] [Related]
9. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic upregulation of urokinase plasminogen activator promotes the tropism of mesenchymal stem cells for tumor cells.
Pulukuri SM; Gorantla B; Dasari VR; Gondi CS; Rao JS
Mol Cancer Res; 2010 Aug; 8(8):1074-83. PubMed ID: 20663859
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.
Paule B; Deslandes E; Le Mouel SP; Bastien L; Podgorniak MP; Allory Y; de la Taille A; Menashi S; Calvo F; Mourah S
Int J Biol Markers; 2010; 25(2):112-5. PubMed ID: 20544684
[TBL] [Abstract] [Full Text] [Related]
12. Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (upaR) for use in alpha-emitter therapy for disseminated ovarian cancer.
Knör S; Sato S; Huber T; Morgenstern A; Bruchertseifer F; Schmitt M; Kessler H; Senekowitsch-Schmidtke R; Magdolen V; Seidl C
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):53-64. PubMed ID: 17891393
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
Hall WA; Vallera DA
Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
[TBL] [Abstract] [Full Text] [Related]
14. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
[TBL] [Abstract] [Full Text] [Related]
15. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (upaR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract] [Full Text] [Related]
16. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C.
Nanbu R; Montero L; D'Orazio D; Nagamine Y
Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023
[TBL] [Abstract] [Full Text] [Related]
